Balchem Corp (BCPC)
NASDAQ • Basic Materials
Last close at September 29, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Balchem Corp keeps $16 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 20
in 20 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Balchem beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 31, 2026, with results led by its Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products portfolio. Revenue rose 11.2% to about $284.0 million (up from roughly $255.5 million a year ago) and topped the $268.5 million estimate (+5.8%), while EPS of $1.40 topped the $1.27 estimate (+10.2%) and was up from $1.27 a year ago. Profitability held at a gross margin of roughly 37% and an operating margin near 21%, alongside operating income of about $59.2 million. Net income increased 16.6% to roughly $44.6 million versus about $38.3 million a year ago. The company generated operating cash flow of around $46.7 million and repurchased about $28.8 million of stock during the quarter. For the next period, consensus calls for EPS of $1.54 on revenue of $289.2 million.
Next report — what to expect
Balchem Corp (BCPC) reports next on October 20, 2026. Wall Street expects EPS of $1.54 on revenue of $289.2 million. For trailing context, revenue grew +11.2% year over year last quarter. BCPC has beaten EPS in 4 of its 8 most recent quarters, making results versus consensus a key watch.
About Balchem Corp
Balchem Corp is a specialty chemicals company listed on NASDAQ under BCPC that develops ingredient, nutrient, and sterilization products for food, beverage, health, agricultural, and industrial markets worldwide. Across Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, it generated $1.0 billion of revenue in FY2025.
Today's Snapshot
BCPC closed 0.9% lower at 167.15. Trading was lighter than usual, with volume about half of its usual level.
Trading Volume
Below 10d avg (234.7K)
134.1K
vs S&P 500 Today
Underperforming Market
-0.73%
Updated: September 29, 2026 at 20:19 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$166.21 - $170.08Sell
- RSI (14)42.83Neutral
- Stochastic %K (14, 3, 3)57.94Neutral
- MACD Level (12, 26)-1.49Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.